BALPHARMA — Bal Pharma Balance Sheet
0.000.00%
- IN₹1.20bn
- IN₹2.64bn
- IN₹3.03bn
- 60
- 45
- 13
- 30
Annual balance sheet for Bal Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 56.5 | 74.5 | 90.8 | 211 | 118 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 693 | 778 | 951 | 1,011 | 946 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,641 | 1,846 | 2,282 | 2,342 | 2,349 |
| Net Property, Plant And Equipment | 575 | 572 | 622 | 648 | 738 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,401 | 2,605 | 3,132 | 3,198 | 3,357 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,525 | 1,656 | 2,093 | 2,031 | 2,195 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,865 | 2,019 | 2,494 | 2,478 | 2,583 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 536 | 586 | 638 | 720 | 774 |
| Total Liabilities & Shareholders' Equity | 2,401 | 2,605 | 3,132 | 3,198 | 3,357 |
| Total Common Shares Outstanding |